Medical devices, healthcare technology and the business of care
510(k) clearance · K262364

Ellian Enigma RF Device

Ellian Corp · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONK262364

What did the FDA decide?

FDA's 510(k) record K262364 covers the Ellian Enigma RF Device, submitted by Ellian Corp of Plano, Texas, and assigned to the electrosurgical cutting and coagulation accessories classification under regulation 878.4400, product code GEI, with the General and Plastic Surgery panel. The agency received the traditional premarket notification on July 10, 2026, and issued a substantially equivalent decision on September 2, 2026. The record states that the submission was not reviewed by a third party, was not a combination product, and included no authorized predetermined change control plan.

The available documents indicate that the clearance rests on a comparison of intended use, technological characteristics and performance data against the predicate device VIVACE. Substantial equivalence is a 510(k) clearance rather than a premarket approval, and the record does not establish approval of the device as a PMA. The source material does not provide the specific indications for use, the technological differences from the predicate, or the performance data reviewed, so those details remain unknown from this record.

The public page also lists Julie Summerville as applicant and correspondent contact, and the device classification name as electrosurgical cutting and coagulation accessories. No clinical or efficacy conclusions are drawn here, and the record does not describe any change to an existing cleared device.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262364
Regulatory pathway
510(k) premarket notification
Applicant
Ellian Corp
Product code
GEI
Decision code
SESE
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Electrosurgical, Cutting & Coagulation & Accessories.

Applicant
Ellian Corp
Product code
GEI
FDA device class
2

FDA decision timeline

  1. K262364 received

    Application receipt date recorded by FDA.

  2. K262364 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GEI

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ellian Corp

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Plano, TX

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records